Understanding Health, Illness, and Disease in Health and Social Care: Biological and Genetic Influences with a Focus on Cystic Fibrosis

Introduction

Health and social care is a multidisciplinary field that requires a comprehensive understanding of concepts such as health, illness, and disease to effectively support individuals and communities. These terms are not merely descriptive but are embedded with social, biological, and cultural implications that shape care practices. Furthermore, biological and genetic factors play a significant role in determining human health outcomes, influencing susceptibility to various conditions. Among these, genetically inherited diseases like cystic fibrosis present unique challenges in health and social care, requiring targeted interventions. This essay aims to define and contextualise key concepts of health, illness, and disease within health and social care, explore critical biological and genetic factors affecting health, and discuss cystic fibrosis as a case study of a genetic illness. By drawing on academic literature and evidence, this work seeks to provide a broad understanding of these topics, highlighting their relevance to epidemiology and health science.

Defining Health, Illness, and Disease in Health and Social Care

The concept of health extends beyond the mere absence of disease; it encompasses physical, mental, and social well-being, as defined by the World Health Organization (WHO, 1948). This holistic perspective is crucial in health and social care, where professionals aim to support individuals in achieving optimal functioning within their environments. However, health is not a static state—it is influenced by a range of factors, including lifestyle, environment, and biology (Dahlgren and Whitehead, 1991). For instance, access to healthcare services and social support can significantly enhance health outcomes, particularly for marginalised groups (Marmot and Wilkinson, 2006).

Illness, on the other hand, refers to the subjective experience of feeling unwell, often shaped by cultural and personal perceptions. As Kleinman (1980) argues, illness is not solely a biological phenomenon but a socially constructed experience that varies across contexts. In health and social care, understanding a patient’s perception of their illness is vital for providing person-centered care, especially when addressing mental health or chronic conditions where stigma may play a role (Scambler, 2009).

Disease, by contrast, is typically understood as a pathological process or abnormality within the body, often diagnosed through clinical measures. According to Engel (1977), the biomedical model dominates in identifying and treating disease, focusing on biological dysfunctions. However, this model has limitations in health and social care, as it often overlooks social determinants and the lived experience of illness (Engel, 1977). Therefore, integrating both biomedical and social models is essential for a comprehensive approach to care (Wade and Halligan, 2004). These concepts collectively inform how health professionals assess, diagnose, and manage conditions, ensuring that care is both evidence-based and empathetic.

Biological and Genetic Factors Influencing Human Health

Biological and genetic factors are fundamental in shaping human health, influencing both individual susceptibility to disease and broader population health trends. At a biological level, factors such as age, sex, and physiological processes impact health outcomes. For example, ageing is associated with a decline in immune function, increasing vulnerability to infections and chronic conditions (Niccoli and Partridge, 2012). Similarly, sex-based differences in biology can influence disease prevalence; cardiovascular disease, for instance, manifests differently in men and women, often with delayed diagnoses in females due to atypical symptoms (Maas and Appelman, 2010).

Genetic factors, however, provide a deeper layer of influence, as they determine inherited traits and predispositions to certain conditions. Genes encode instructions for cellular function, and mutations or variations can lead to health issues. According to McKusick (2007), genetic disorders can be categorised into single-gene disorders, chromosomal abnormalities, and multifactorial conditions influenced by both genetics and environment. For instance, family history is a well-documented risk factor for conditions such as breast cancer, where mutations in the BRCA1 and BRCA2 genes significantly elevate risk (Antoniou et al., 2003). Moreover, epigenetics—the study of how environmental factors affect gene expression—further complicates the relationship between genetics and health, demonstrating that lifestyle choices like diet or stress can modify genetic risks (Feil and Fraga, 2012).

In the context of health and social care, understanding these biological and genetic influences is critical for prevention and intervention strategies. Genetic screening, for example, enables early identification of at-risk individuals, while public health policies can target biological risk factors through vaccination programmes or health education (Rose, 2008). However, there are limitations to focusing solely on biological and genetic determinants, as they do not account for socioeconomic disparities that also shape health outcomes (Marmot and Wilkinson, 2006). Thus, a balanced approach is necessary to address the interplay of biology, genetics, and social factors.

Cystic Fibrosis: A Case Study of a Genetically Inherited Disease

Cystic fibrosis (CF) serves as a pertinent example of a genetically inherited disease with significant implications for health and social care. CF is a life-limiting condition caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, located on chromosome 7. This gene regulates the movement of chloride and water across cell membranes, and mutations lead to the production of thick, sticky mucus that obstructs airways and digestive pathways (Ratjen and Döring, 2003). The condition is autosomal recessive, meaning that an individual must inherit two faulty copies of the gene—one from each parent—to develop the disease. carriers, who possess only one mutated gene, are typically asymptomatic but can pass the mutation to their offspring (Cutting, 2015).

In the UK, CF affects approximately 10,800 individuals, making it one of the most common genetic disorders among people of European descent (Cystic Fibrosis Trust, 2021). Symptoms include chronic respiratory infections, pancreatic insufficiency, and malnutrition, often leading to reduced life expectancy despite advances in treatment (O’Sullivan and Freedman, 2009). The management of CF in health and social care involves a multidisciplinary approach, including physiotherapy, nutritional support, and antibiotic therapies to manage infections (Smyth et al., 2014). Moreover, recent developments in gene therapy and CFTR modulators have shown promise in addressing the underlying genetic defect, though access to these treatments remains limited by cost and availability (Middleton et al., 2019).

The impact of CF extends beyond the physical; it profoundly affects quality of life, mental health, and social interactions. Patients often face challenges such as social isolation due to infection risks and the burden of intensive daily treatments (Sawicki et al., 2009). In health and social care, providing psychological support and social services is therefore as crucial as medical intervention. However, disparities in care persist, with evidence suggesting that socioeconomic status influences access to specialised services and treatment adherence (Schechter et al., 2007). This highlights the need for equitable health policies to ensure comprehensive care for CF patients across diverse populations.

Conclusion

This essay has explored the key concepts of health, illness, and disease within the context of health and social care, demonstrating their interconnectedness and relevance to care delivery. Health is a multifaceted construct that requires a holistic approach, while illness and disease necessitate both subjective understanding and biomedical intervention. Furthermore, biological and genetic factors significantly influence human health, with genetics playing a pivotal role in inherited conditions such as cystic fibrosis. The discussion of CF illustrates the complexity of managing genetic diseases, requiring not only medical expertise but also social and psychological support. The implications of these findings are clear: health and social care professionals must adopt integrative approaches that address both biological determinants and social inequities to improve patient outcomes. Future research should focus on making advanced treatments like gene therapy more accessible, particularly for genetically inherited conditions, while public health strategies should continue to tackle broader determinants of health. This dual focus will ensure that care remains both effective and equitable in addressing the diverse needs of individuals and communities.

References

• Antoniou, A., Pharoah, P.D., Narod, S., Risch, H.A., Eyfjord, J.E., Hopper, J.L., Loman, N., Olsson, H., Johannsson, O., Borg, A., Pasini, B., Radice, P., Manoukian, S., Eccles, D.M., Tang, N., Olah, E., Anton-Culver, H., Warner, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjäkoski, K., Kallioniemi, O.P., Thompson, D., Evans, C., Peto, J., Lalloo, F., Evans, D.G. and Easton, D.F. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics, 72(5), pp.1117-1130.
• Cutting, G.R. (2015) Cystic fibrosis genetics: from molecular understanding to clinical application. Nature Reviews Genetics, 16(1), pp.45-56.
• Cystic Fibrosis Trust (2021) What is cystic fibrosis? Cystic Fibrosis Trust.
• Dahlgren, G. and Whitehead, M. (1991) Policies and strategies to promote social equity in health. Institute for Futures Studies, Stockholm.
• Engel, G.L. (1977) The need for a new medical model: a challenge for biomedicine. Science, 196(4286), pp.129-136.
• Feil, R. and Fraga, M.F. (2012) Epigenetics and the environment: emerging patterns and implications. Nature Reviews Genetics, 13(2), pp.97-109.
• Kleinman, A. (1980) Patients and healers in the context of culture: an exploration of the borderland between anthropology, medicine, and psychiatry. University of California Press.
• Maas, A.H. and Appelman, Y.E. (2010) Gender differences in coronary heart disease. Netherlands Heart Journal, 18(12), pp.598-602.
• Marmot, M. and Wilkinson, R.G. (2006) Social determinants of health. 2nd ed. Oxford University Press.
• McKusick, V.A. (2007) Mendelian inheritance in man and its online version, OMIM. American Journal of Human Genetics, 80(4), pp.588-604.
• Middleton, P.G., Mall, M.A., Dřevínek, P., Lands, L.C., McKone, E.F., Polineni, D., Ramsey, B.W., Taylor-Cousar, J.L., Tullis, E., Vermeulen, F., Marigowda, G., McKee, C.M., Moskowitz, S.M., Nair, N., Savage, J., Simard, C. and Tian, S. (2019) Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. New England Journal of Medicine, 381(19), pp.1809-1819.
• Niccoli, T. and Partridge, L. (2012) Ageing as a risk factor for disease. Current Biology, 22(17), pp.R741-R752.
• O’Sullivan, B.P. and Freedman, S.D. (2009) Cystic fibrosis. The Lancet, 373(9678), pp.1891-1904.
• Ratjen, F. and Döring, G. (2003) Cystic fibrosis. The Lancet, 361(9358), pp.681-689.
• Rose, G. (2008) Rose’s strategy of preventive medicine. Oxford University Press.
• Sawicki, G.S., Sellers, D.E. and Robinson, W.M. (2009) High treatment burden in adults with cystic fibrosis: challenges to disease self-management. Journal of Cystic Fibrosis, 8(2), pp.91-96.
• Scambler, G. (2009) Health-related stigma. Sociology of Health & Illness, 31(3), pp.441-455.
• Schechter, M.S., Shelton, B.J., Margolis, P.A. and Fitzsimmons, S.C. (2007) The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. American Journal of Respiratory and Critical Care Medicine, 163(6), pp.1331-1337.
• Smyth, A.R., Bell, S.C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S.J., Sermet-Gaudelus, I., Southern, K.W., Taccetti, G., Ullrich, G. and Wolfe, S. (2014) European Cystic Fibrosis Society standards of care: best practice guidelines. Journal of Cystic Fibrosis, 13(Suppl 1), pp.S23-S42.
• Wade, D.T. and Halligan, P.W. (2004) Do biomedical models of illness make for good healthcare systems? BMJ, 329(7479), pp.1398-1401.
• World Health Organization (WHO) (1948) Constitution of the World Health Organization. WHO.